TreeWAS – Variant ID: rs2849691

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C44.3 Skin of other and unspecified parts of face	0.000	0.000	1.000
C44 Other malignant neoplasms of skin	0.000	0.000	1.000
C44.5 Skin of trunk	0.000	0.000	1.000
C44.7 Skin of lower limb, including hip	0.000	0.009	0.991
C44.6 Skin of upper limb, including shoulder	0.000	0.028	0.972
C44.9 Malignant neoplasm of skin, unspecified	0.000	0.256	0.744
C44.4 Skin of scalp and neck	0.000	0.280	0.720
C44.8 Overlapping lesion of skin	0.000	0.283	0.717
C44.0 Skin of lip	0.000	0.300	0.700
C44.2 Skin of ear and external auricular canal	0.000	0.569	0.431
C44.1 Skin of eyelid, including canthus	0.000	0.609	0.391
C43-C44 Melanoma and other malignant neoplasms of skin	0.000	0.613	0.387
C43 Malignant melanoma of skin	0.000	0.737	0.262
C43.5 Malignant melanoma of trunk	0.000	0.762	0.238
C43.4 Malignant melanoma of scalp and neck	0.000	0.768	0.232
C43.8 Overlapping malignant melanoma of skin	0.000	0.812	0.188
C43.0 Malignant melanoma of lip	0.000	0.812	0.188
C43.2 Malignant melanoma of ear and external auricular canal	0.000	0.812	0.188
C43.9 Malignant melanoma of skin, unspecified	0.000	0.812	0.188
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.826	0.174
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.841	0.159
C43.3 Malignant melanoma of other and unspecified parts of face	0.000	0.891	0.109
C43.6 Malignant melanoma of upper limb, including shoulder	0.000	0.921	0.079
L57.0 Actinic keratosis	0.000	0.972	0.028
G95.2 Cord compression, unspecified	0.026	0.974	0.000
C34.9 Bronchus or lung, unspecified	0.025	0.975	0.000
C34.2 Middle lobe, bronchus or lung	0.024	0.976	0.000
C34 Malignant neoplasm of bronchus and lung	0.023	0.977	0.000
C34.0 Main bronchus	0.019	0.981	0.000
C34.8 Overlapping lesion of bronchus and lung	0.017	0.983	0.000
Y42.7 Androgens and anabolic congeners	0.016	0.984	0.000
C34.1 Upper lobe, bronchus or lung	0.016	0.984	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.986	0.014
D14.0 Middle ear, nasal cavity and accessory sinuses	0.000	0.987	0.013
L57 Skin changes due to chronic exposure to nonionising radiation	0.000	0.987	0.013
G43.1 Migraine with aura [classical migraine]	0.012	0.988	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.011	0.989	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.011	0.989	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.989	0.011
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.010	0.990	0.000
Z90.5 Acquired absence of kidney	0.010	0.990	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.010	0.990	0.000
L57.3 Poikiloderma of Civatte	0.000	0.991	0.009
L57.2 Cutis rhomboidalis nuchae	0.000	0.991	0.009
L57.1 Actinic reticuloid	0.000	0.991	0.009
H65 Nonsuppurative otitis media	0.009	0.991	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
H65.2 Chronic serous otitis media	0.009	0.991	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.009	0.991	0.000
G43.8 Other migraine	0.009	0.991	0.000
L57.5 Actinic granuloma	0.000	0.991	0.009
Y42.2 Antithyroid drugs	0.009	0.991	0.000
Z90.3 Acquired absence of part of stomach	0.008	0.992	0.000
C33 Malignant neoplasm of trachea	0.008	0.992	0.000
Y42.9 Other and unspecified hormone antagonists	0.008	0.992	0.000
Y42.4 Oral contraceptives	0.008	0.992	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.008	0.992	0.000
G43 Migraine	0.008	0.992	0.000
C31 Malignant neoplasm of accessory sinuses	0.008	0.992	0.000
C34.3 Lower lobe, bronchus or lung	0.008	0.992	0.000
C37 Malignant neoplasm of thymus	0.008	0.992	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.008	0.992	0.000
H65.0 Acute serous otitis media	0.008	0.992	0.000
H65.3 Chronic mucoid otitis media	0.008	0.992	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.008	0.992	0.000
Y42.1 Thyroid hormones and substitutes	0.008	0.992	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.008	0.992	0.000
Z71.3 Dietary counselling and surveillance	0.008	0.992	0.000
G43.0 Migraine without aura [common migraine]	0.007	0.992	0.000
L57.4 Cutis laxa senilis	0.000	0.993	0.007
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.007	0.993	0.000
H65.4 Other chronic nonsuppurative otitis media	0.007	0.993	0.000
F06.7 Mild cognitive disorder	0.007	0.993	0.000
C38.3 Mediastinum, part unspecified	0.007	0.993	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.000	0.993	0.007
H65.1 Other acute nonsuppurative otitis media	0.007	0.993	0.000
C31.0 Maxillary sinus	0.007	0.993	0.000
Z90.0 Acquired absence of part of head and neck	0.007	0.993	0.000
S42.0 Fracture of clavicle	0.000	0.994	0.006
G43.3 Complicated migraine	0.006	0.994	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.994	0.006
Y42.5 Other oestrogens and progestogens	0.006	0.994	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.006	0.994	0.000
C38.2 Posterior mediastinum	0.006	0.994	0.000
C38.1 Anterior mediastinum	0.006	0.994	0.000
C38.0 Heart	0.006	0.994	0.000
G43.2 Status migrainosus	0.006	0.994	0.000
C31.9 Accessory sinus, unspecified	0.006	0.994	0.000
C31.8 Overlapping lesion of accessory sinuses	0.006	0.994	0.000
C31.3 Sphenoidal sinus	0.006	0.994	0.000
C31.2 Frontal sinus	0.006	0.994	0.000
C31.1 Ethmoidal sinus	0.006	0.994	0.000
C38.4 Pleura	0.006	0.994	0.000
Y43.1 Antineoplastic antimetabolites	0.006	0.994	0.000
Z90 Acquired absence of organs, not elsewhere classified	0.006	0.994	0.000
C39.9 Ill-defined sites within the respiratory system	0.006	0.994	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.006	0.994	0.000
C39.0 Upper respiratory tract, part unspecified	0.006	0.994	0.000
C30.1 Middle ear	0.006	0.994	0.000
C30.0 Nasal cavity	0.005	0.994	0.000
Y57 Other and unspecified drugs and medicaments	0.006	0.994	0.000
C32 Malignant neoplasm of larynx	0.005	0.995	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
M79.79 Fibromyalgia (Site unspecified)	0.005	0.995	0.000
Y57.9 Drug or medicament, unspecified	0.005	0.995	0.000
L56 Other acute skin changes due to ultraviolet radiation	0.000	0.995	0.005
G95 Other diseases of spinal cord	0.005	0.995	0.000
F41.2 Mixed anxiety and depressive disorder	0.005	0.995	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
Y52 Agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.005	0.995	0.000
Y95 Nosocomial condition	0.005	0.995	0.000
S42.01 Fracture of clavicle (open)	0.000	0.995	0.005
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.000	0.995	0.005
L58 Radiodermatitis	0.000	0.995	0.005
L55 Sunburn	0.000	0.995	0.005
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y57.6 Other diagnostic agents	0.005	0.995	0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.000	0.995	0.005
Y43 Primarily systemic agents	0.005	0.995	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
M94.88 Other specified disorders of cartilage (Other)	0.000	0.995	0.005
Y57.8 Other drugs and medicaments	0.005	0.995	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Z90.2 Acquired absence of lung [part of]	0.004	0.996	0.000
C32.9 Larynx, unspecified	0.004	0.996	0.000
D22.5 Melanocytic naevi of trunk	0.000	0.996	0.004
D14 Benign neoplasm of middle ear and respiratory system	0.000	0.996	0.004
Y59 Other and unspecified vaccines and biological substances	0.004	0.996	0.000
Y40.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
Y57.7 Vitamins, not elsewhere classified	0.004	0.996	0.000
Y57.5 X-ray contrast media	0.004	0.996	0.000
Y57.4 Pharmaceutical excipients	0.004	0.996	0.000
Y57.3 Alcohol deterrents	0.004	0.996	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.004	0.996	0.000
Y57.1 Lipotropic drugs	0.004	0.996	0.000
Y57.0 Appetite depressants [anorectics]	0.004	0.996	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
C32.8 Overlapping lesion of larynx	0.004	0.996	0.000
C32.3 Laryngeal cartilage	0.004	0.996	0.000
C32.2 Subglottis	0.004	0.996	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
L56.4 Polymorphous light eruption	0.000	0.996	0.004
L56.3 Solar urticaria	0.000	0.996	0.004
L56.2 Photocontact dermatitis [berloque dermatitis]	0.000	0.996	0.004
L56.1 Drug photoallergic response	0.000	0.996	0.004
L56.0 Drug phototoxic response	0.000	0.996	0.004
Y58 Bacterial vaccines	0.004	0.996	0.000
E87.5 Hyperkalaemia	0.004	0.996	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Z90.8 Acquired absence of other organs	0.004	0.996	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.004	0.996	0.000
Z90.6 Acquired absence of other parts of urinary tract	0.004	0.996	0.000
G95.8 Other specified diseases of spinal cord	0.004	0.996	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
Y59.0 Viral vaccines	0.004	0.996	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.004	0.996	0.000
Y49.2 Other and unspecified antidepressants	0.004	0.996	0.000
C32.1 Supraglottis	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.000	0.996	0.004
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.000	0.996	0.004
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.000	0.996	0.004
L59.0 Erythema ab igne [dermatitis ab igne]	0.000	0.996	0.004
Y40 Systemic antibiotics	0.004	0.996	0.000
L55.9 Sunburn, unspecified	0.000	0.996	0.003
L55.8 Other sunburn	0.000	0.996	0.003
L55.2 Sunburn of third degree	0.000	0.996	0.003
L55.1 Sunburn of second degree	0.000	0.996	0.003
L55.0 Sunburn of first degree	0.000	0.996	0.003
L58.9 Radiodermatitis, unspecified	0.000	0.996	0.003
L58.1 Chronic radiodermatitis	0.000	0.996	0.003
L58.0 Acute radiodermatitis	0.000	0.996	0.003
G95.1 Vascular myelopathies	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
D22.0 Melanocytic naevi of lip	0.000	0.996	0.004
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.004	0.996	0.000
D14.3 Bronchus and lung	0.000	0.996	0.004
G95.9 Disease of spinal cord, unspecified	0.004	0.996	0.000
Y43.9 Primarily systemic agent, unspecified	0.003	0.996	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.996	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.996	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.996	0.000
Y43.2 Antineoplastic natural products	0.003	0.996	0.000
Y52.1 Calcium-channel blockers	0.004	0.996	0.000
S52.00 Fracture of upper end of ulna (closed)	0.004	0.996	0.000
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.996	0.004
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
Y52.7 Peripheral vasodilators	0.003	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.996	0.000
Y41.5 Antiviral drugs	0.003	0.996	0.000
Y43.4 Immunosuppressive agents	0.003	0.996	0.000
I71 Aortic aneurysm and dissection	0.004	0.996	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
D14.4 Respiratory system, unspecified	0.000	0.997	0.003
D14.2 Trachea	0.000	0.997	0.003
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.003	0.997	0.000
T21.1 Burn of first degree of trunk	0.003	0.997	0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
D22 Melanocytic naevi	0.000	0.997	0.003
D12.2 Ascending colon	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y91 Evidence of alcohol involvement determined by level of intoxication	0.003	0.997	0.000
T21 Burn and corrosion of trunk	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
T20.2 Burn of second degree of head and neck	0.003	0.997	0.000
I71.0 Dissection of aorta [any part]	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
D22.9 Melanocytic naevi, unspecified	0.000	0.997	0.003
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level	0.003	0.997	0.000
T21.0 Burn of unspecified degree of trunk	0.003	0.997	0.000
V49.8 Car occupant [any] injured in other specified transport accidents	0.003	0.997	0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident	0.003	0.997	0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident	0.003	0.997	0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
K04.5 Chronic apical periodontitis	0.000	0.997	0.003
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
T20.1 Burn of first degree of head and neck	0.003	0.997	0.000
T21.2 Burn of second degree of trunk	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.000	0.997	0.003
Y91.9 Alcohol involvement, not otherwise specified	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y98 Lifestyle-related condition	0.003	0.997	0.000
Y97 Environmental-pollution-related condition	0.003	0.997	0.000
Y96 Work-related condition	0.003	0.997	0.000
W05.0 Home	0.003	0.997	0.000
T20 Burn and corrosion of head and neck	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
I71.1 Thoracic aortic aneurysm, ruptured	0.003	0.997	0.000
K80.4 Calculus of bile duct with cholecystitis	0.000	0.997	0.003
W05.9 Unspecified place	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
W05 Fall involving wheelchair	0.003	0.997	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.003	0.997	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
D22.4 Melanocytic naevi of scalp and neck	0.000	0.997	0.003
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
Y90.6 Blood alcohol level of 120-199 mg/100 ml	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.997	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.002	0.997	0.000
F06.5 Organic dissociative disorder	0.002	0.997	0.000
F06.4 Organic anxiety disorder	0.002	0.997	0.000
F06.3 Organic mood [affective] disorders	0.002	0.997	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.002	0.997	0.000
F06.1 Organic catatonic disorder	0.002	0.997	0.000
F06.0 Organic hallucinosis	0.002	0.997	0.000
H43.8 Other disorders of vitreous body	0.000	0.997	0.003
O23.4 Unspecified infection of urinary tract in pregnancy	0.000	0.997	0.003
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.997	0.000
W05.2 School, other institution and public administrative area	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.997	0.000
Y44.7 Plasma substitutes	0.002	0.997	0.000
Y44.6 Natural blood and blood products	0.002	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
Y53.7 Emetics	0.002	0.997	0.000
Y53.5 Digestants	0.002	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.997	0.000
Y53.2 Stimulant laxatives	0.002	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.997	0.000
Y91.3 Very severe alcohol intoxication	0.002	0.997	0.000
Y91.2 Severe alcohol intoxication	0.002	0.997	0.000
Y91.1 Moderate alcohol intoxication	0.002	0.997	0.000
Y91.0 Mild alcohol intoxication	0.002	0.997	0.000
V40-V49 Car occupant injured in transport accident	0.003	0.997	0.000
T21.7 Corrosion of third degree of trunk	0.002	0.997	0.000
T21.6 Corrosion of second degree of trunk	0.002	0.997	0.000
T21.5 Corrosion of first degree of trunk	0.002	0.997	0.000
T21.4 Corrosion of unspecified degree of trunk	0.002	0.997	0.000
W17.6 Industrial and construction area	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.002	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.997	0.000
Y54.0 Mineralocorticoids	0.002	0.997	0.000
F41.1 Generalised anxiety disorder	0.003	0.997	0.000
N89.5 Stricture and atresia of vagina	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.002	0.997	0.000
G95.0 Syringomyelia and syringobulbia	0.002	0.997	0.001
N89.6 Tight hymenal ring	0.003	0.997	0.000
M66.24 Spontaneous rupture of extensor tendons (Hand)	0.002	0.997	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.000	0.997	0.003
I71.3 Abdominal aortic aneurysm, ruptured	0.002	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.997	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.002	0.997	0.000
Y46.8 Antispasticity drugs	0.002	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.997	0.000
Y46.5 Valproic acid	0.002	0.997	0.000
Y46.3 Deoxybarbiturates	0.002	0.997	0.000
Y46.1 Oxazolidinediones	0.002	0.997	0.000
Y46.0 Succinimides	0.002	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.997	0.000
T21.3 Burn of third degree of trunk	0.002	0.998	0.000
Y90.9 Presence of alcohol in blood, level not specified	0.002	0.998	0.000
Y90.7 Blood alcohol level of 200-239 mg/100 ml	0.002	0.998	0.000
Y90.5 Blood alcohol level of 100-119 mg/100 ml	0.002	0.998	0.000
Y90.4 Blood alcohol level of 80-99 mg/100 ml	0.002	0.998	0.000
Y90.3 Blood alcohol level of 60-79 mg/100 ml	0.002	0.998	0.000
Y90.2 Blood alcohol level of 40-59 mg/100 ml	0.002	0.998	0.000
Y90.1 Blood alcohol level of 20-39 mg/100 ml	0.002	0.998	0.000
Y90.0 Blood alcohol level of less than 20 mg/100 ml	0.002	0.998	0.000
V49.81 Car occupant injured in trnsp accident w military vehicle (Car occupant (driver) (passenger) injured in transport accident with military vehicle)	0.002	0.998	0.000
W17.4 Street and highway	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y90.8 Blood alcohol level of 240 mg/100 ml or more	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
M94.8 Other specified disorders of cartilage	0.000	0.998	0.002
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
D14.1 Larynx	0.000	0.998	0.002
T20.7 Corrosion of third degree of head and neck	0.002	0.998	0.000
T20.6 Corrosion of second degree of head and neck	0.002	0.998	0.000
T20.5 Corrosion of first degree of head and neck	0.002	0.998	0.000
T20.4 Corrosion of unspecified degree of head and neck	0.002	0.998	0.000
T20.3 Burn of third degree of head and neck	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.002	0.998	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.002	0.998	0.000
W05.8 Other specified place	0.002	0.998	0.000
W05.7 Farm	0.002	0.998	0.000
W05.6 Industrial and construction area	0.002	0.998	0.000
W05.5 Trade and service area	0.002	0.998	0.000
W05.4 Street and highway	0.002	0.998	0.000
W05.3 Sports and athletics area	0.002	0.998	0.000
W05.1 Residential institution	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
W17 Other fall from one level to another	0.002	0.998	0.000
M60.08 Infective myositis (Other)	0.002	0.998	0.000
W10.4 Street and highway	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
K75.0 Abscess of liver	0.000	0.998	0.002
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.002	0.998	0.000
M66.06 Rupture of popliteal cyst-Lower leg	0.002	0.998	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
M60.05 Infective myositis (Pelvic region and thigh)	0.002	0.998	0.000
M66.2 Spontaneous rupture of extensor tendons	0.002	0.998	0.000
B91 Sequelae of poliomyelitis	0.002	0.998	0.000
M25.84 Other specified joint disorders (Hand)	0.002	0.998	0.000
M85.00 Fibrous dysplasia (monostotic) (Multiple sites)	0.000	0.998	0.002
C32.0 Glottis	0.002	0.998	0.000
V43 Car occupant injured in collision with car, pick-up truck or van	0.002	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
V47 Car occupant injured in collision with fixed or stationary object	0.002	0.998	0.000
V46 Car occupant injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V45 Car occupant injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V41 Car occupant injured in collision with pedal cycle	0.002	0.998	0.000
V40 Car occupant injured in collision with pedestrian or animal	0.002	0.998	0.000
N41.1 Chronic prostatitis	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.002	0.998	0.000
M79.7 Fibromyalgia	0.002	0.998	0.000
T20.0 Burn of unspecified degree of head and neck	0.002	0.998	0.000
M66.31 Spontaneous rupture of flexor tendons (Shoulder region)	0.002	0.998	0.000
J34.8 Other specified disorders of nose and nasal sinuses	0.000	0.998	0.002
X10-X19 Contact with heat and hot substances	0.002	0.998	0.000
M66.3 Spontaneous rupture of flexor tendons	0.002	0.998	0.000
M66.0 Rupture of popliteal cyst	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
F41 Other anxiety disorders	0.002	0.998	0.000
N89 Other noninflammatory disorders of vagina	0.002	0.998	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.000	0.998	0.002
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.998	0.002
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.998	0.002
Z50.5 Speech therapy	0.000	0.998	0.002
V48 Car occupant injured in noncollision transport accident	0.002	0.998	0.000
X10 Contact with hot drinks, food, fats and cooking oils	0.002	0.998	0.000
M66.33 Spontaneous rupture of flexor tendons (Forearm)	0.002	0.998	0.000
D22.2 Melanocytic naevi of ear and external auricular canal	0.000	0.998	0.002
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.000	0.998	0.002
W17.3 Sports and athletics area	0.002	0.998	0.000
X10.0 Home	0.002	0.998	0.000
W10 Fall on and from stairs and steps	0.002	0.998	0.000
V89.9 Person injured in unspecified vehicle accident	0.002	0.998	0.000
Y53.4 Other laxatives	0.001	0.998	0.001
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
M66 Spontaneous rupture of synovium and tendon	0.002	0.998	0.000
X19 Contact with other and unspecified heat and hot substances	0.002	0.998	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.998	0.002
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.998	0.002
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.998	0.002
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.998	0.002
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.998	0.002
K51.4 Pseudopolyposis of colon	0.002	0.998	0.000
K83.0 Cholangitis	0.000	0.998	0.002
Y04.8 Other specified place	0.002	0.998	0.000
X16 Contact with hot heating appliances, radiators and pipes	0.002	0.998	0.000
M60.0 Infective myositis	0.002	0.998	0.000
N89.1 Moderate vaginal dysplasia	0.002	0.998	0.000
T63.4 Venom of other arthropods	0.000	0.998	0.002
L29.0 Pruritus ani	0.002	0.998	0.000
O47.0 False labour before 37 completed weeks of gestation	0.000	0.998	0.002
X16.0 Home	0.002	0.998	0.000
T25 Burn and corrosion of ankle and foot	0.002	0.998	0.000
I74.5 Embolism and thrombosis of iliac artery	0.000	0.998	0.002
S52.0 Fracture of upper end of ulna	0.002	0.998	0.000
W17.9 Unspecified place	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations